| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.742 | 0.019 | 0.802 | Caspase 9 stimulant | 0.802 0.011 DBMET01637 0.79 0.013 DBMET01638 0.772 0.015 DBMET01639 | DBMET01637 | |
| 0.673 | 0.01 | 0.829 | Aldehyde oxidase inhibitor | 0.829 0.004 DBMET01637 0.773 0.005 DBMET01638 0.604 0.018 DBMET01639 | DBMET01637 | |
| 0.65 | 0.006 | 0.666 | 5 Hydroxytryptamine release inhibitor | 0.666 0.005 DBMET01637 0.656 0.005 DBMET01638 0.508 0.03 DBMET01639 | DBMET01637 | |
| 0.641 | 0.002 | 0.678 | 5 Hydroxytryptamine uptake stimulant | 0.678 0.002 DBMET01637 0.55 0.004 DBMET01638 0.459 0.006 DBMET01639 | DBMET01637 | |
| 0.644 | 0.008 | 0.743 | Caspase 3 stimulant | 0.678 0.006 DBMET01637 0.434 0.034 DBMET01638 0.743 0.005 DBMET01639 | DBMET01639 | |
| 0.619 | 0.005 | 0.682 | GABA C receptor rho-3 antagonist | 0.682 0.004 DBMET01637 0.6 0.007 DBMET01638 0.454 0.04 DBMET01639 | DBMET01637 | |
| 0.61 | 0.014 | 0.61 | Aryl hydrocarbon receptor agonist | 0.608 0.014 DBMET01637 0.371 0.043 DBMET01638 | ||
| 0.588 | 0.011 | 0.652 | Histamine release inhibitor | 0.652 0.006 DBMET01637 0.649 0.007 DBMET01638 0.481 0.036 DBMET01639 | DBMET01637 | |
| 0.619 | 0.045 | 0.763 | Apoptosis agonist | 0.696 0.032 DBMET01637 0.763 0.021 DBMET01638 0.716 0.028 DBMET01639 | DBMET01638 | |
| 0.562 | 0.019 | 0.579 | 5 Hydroxytryptamine release stimulant | 0.487 0.029 DBMET01637 0.579 0.017 DBMET01638 0.411 0.044 DBMET01639 | DBMET01638 | |
| 0.539 | 0.003 | 0.653 | Carbonic anhydrase XV inhibitor | 0.653 0.002 DBMET01637 0.382 0.004 DBMET01638 0.221 0.015 DBMET01639 | DBMET01637 | |
| 0.546 | 0.01 | 0.687 | Amyloid beta aggregation inhibitor | 0.687 0.005 DBMET01637 0.468 0.017 DBMET01638 | DBMET01637 | |
| 0.543 | 0.012 | 0.863 | Free radical scavenger | 0.712 0.005 DBMET01637 0.863 0.004 DBMET01638 0.284 0.056 DBMET01639 | DBMET01638 | |
| 0.551 | 0.032 | 0.685 | 15-Lipoxygenase inhibitor | 0.685 0.014 DBMET01637 0.671 0.015 DBMET01638 | DBMET01637 | |
| 0.522 | 0.005 | 0.522 | Acetylcholinesterase inhibitor | 0.502 0.005 DBMET01637 0.25 0.02 DBMET01638 | ||
| 0.528 | 0.017 | 0.811 | Antioxidant | 0.7 0.006 DBMET01637 0.811 0.004 DBMET01638 0.441 0.028 DBMET01639 | DBMET01638 | |
| 0.515 | 0.007 | 0.635 | MAO inhibitor | 0.635 0.005 DBMET01637 0.359 0.015 DBMET01638 0.184 0.046 DBMET01639 | DBMET01637 | |
| 0.475 | 0.003 | 0.664 | Carbonic anhydrase III inhibitor | 0.664 0.002 DBMET01637 0.377 0.004 DBMET01638 0.179 0.02 DBMET01639 | DBMET01637 | |
| 0.482 | 0.018 | 0.491 | Vasodilator, coronary | 0.491 0.017 DBMET01637 0.369 0.047 DBMET01638 0.344 0.058 DBMET01639 | DBMET01637 | |
| 0.467 | 0.007 | 0.467 | Cholinergic | 0.417 0.009 DBMET01637 0.179 0.057 DBMET01638 | ||
| 0.528 | 0.072 | 0.661 | Alpha-glucosidase inhibitor | 0.661 0.041 DBMET01637 0.655 0.042 DBMET01638 | DBMET01637 | |
| 0.46 | 0.005 | 0.572 | MAO B inhibitor | 0.572 0.004 DBMET01637 0.312 0.012 DBMET01638 0.149 0.037 DBMET01639 | DBMET01637 | |
| 0.477 | 0.026 | 0.521 | Spasmolytic | 0.521 0.02 DBMET01637 0.292 0.073 DBMET01638 0.278 0.079 DBMET01639 | DBMET01637 | |
| 0.46 | 0.013 | 0.658 | Peroxidase inhibitor | 0.658 0.004 DBMET01637 0.634 0.004 DBMET01638 0.333 0.031 DBMET01639 | DBMET01637 | |
| 0.487 | 0.046 | 0.633 | Transcription factor NF kappa B inhibitor | 0.633 0.027 DBMET01637 0.497 0.045 DBMET01638 0.37 0.071 DBMET01639 | DBMET01637 | |
| 0.443 | 0.007 | 0.549 | MAO A inhibitor | 0.549 0.005 DBMET01637 0.267 0.019 DBMET01638 | DBMET01637 | |
| 0.428 | 0.003 | 0.428 | CYP2A6 inhibitor | 0.284 0.004 DBMET01637 0.198 0.008 DBMET01638 0.164 0.013 DBMET01639 | ||
| 0.441 | 0.017 | 0.444 | Vasodilator | 0.444 0.017 DBMET01637 0.263 0.063 DBMET01638 | DBMET01637 | |
| 0.469 | 0.048 | 0.494 | Prostaglandin dehydrogenase inhibitor | 0.494 0.043 DBMET01637 0.291 0.106 DBMET01638 | DBMET01637 | |
| 0.418 | 0.004 | 0.418 | 3C-like protease (Human coronavirus) inhibitor | 0.352 0.005 DBMET01637 0.273 0.019 DBMET01638 0.19 0.058 DBMET01639 | ||
| 0.409 | 0.004 | 0.619 | Carbonic anhydrase XIII inhibitor | 0.619 0.003 DBMET01637 0.298 0.006 DBMET01638 0.131 0.026 DBMET01639 | DBMET01637 | |
| 0.408 | 0.004 | 0.585 | Carbonic anhydrase VI inhibitor | 0.585 0.003 DBMET01637 0.303 0.006 DBMET01638 0.12 0.029 DBMET01639 | DBMET01637 | |
| 0.408 | 0.025 | 0.499 | Superoxide dismutase inhibitor | 0.499 0.013 DBMET01637 0.471 0.016 DBMET01638 0.214 0.103 DBMET01639 | DBMET01637 | |
| 0.385 | 0.003 | 0.4 | Photosensitizer | 0.4 0.003 DBMET01637 0.259 0.005 DBMET01638 0.172 0.02 DBMET01639 | DBMET01637 | |
| 0.383 | 0.006 | 0.383 | Butyrylcholinesterase inhibitor | 0.343 0.008 DBMET01637 0.135 0.04 DBMET01638 | ||
| 0.395 | 0.03 | 0.427 | DNA damaging | 0.427 0.023 DBMET01637 0.277 0.067 DBMET01638 0.233 0.09 DBMET01639 | DBMET01637 | |
| 0.399 | 0.038 | 0.571 | Lipoxygenase inhibitor | 0.532 0.015 DBMET01637 0.571 0.012 DBMET01638 | DBMET01638 | |
| 0.399 | 0.039 | 0.493 | Apoptosis antagonist | 0.493 0.021 DBMET01637 0.352 0.055 DBMET01638 0.273 0.106 DBMET01639 | DBMET01637 | |
| 0.391 | 0.032 | 0.478 | Hypoxia-inducible factor 1 alpha inhibitor | 0.478 0.017 DBMET01637 0.308 0.062 DBMET01638 0.2 0.152 DBMET01639 | DBMET01637 | |
| 0.36 | 0.014 | 0.443 | Tyrosine 3 hydroxylase inhibitor | 0.443 0.005 DBMET01637 0.384 0.01 DBMET01638 0.276 0.047 DBMET01639 | DBMET01637 | |
| 0.425 | 0.08 | 0.425 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.313 0.195 DBMET01637 0.322 0.184 DBMET01638 0.336 0.167 DBMET01639 | ||
| 0.373 | 0.029 | 0.483 | Nitric oxide antagonist | 0.463 0.019 DBMET01637 0.267 0.047 DBMET01638 0.483 0.017 DBMET01639 | DBMET01639 | |
| 0.355 | 0.013 | 0.55 | Amylase inhibitor | 0.55 0.005 DBMET01637 0.311 0.017 DBMET01638 0.164 0.057 DBMET01639 | DBMET01637 | |
| 0.345 | 0.004 | 0.458 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.458 0.003 DBMET01637 0.314 0.004 DBMET01638 0.182 0.012 DBMET01639 | DBMET01637 | |
| 0.357 | 0.015 | 0.544 | Melanin inhibitor | 0.544 0.005 DBMET01637 0.324 0.019 DBMET01638 0.216 0.035 DBMET01639 | DBMET01637 | |
| 0.346 | 0.007 | 0.636 | Cystathionine beta-synthase inhibitor | 0.636 0.003 DBMET01637 0.492 0.004 DBMET01638 0.257 0.014 DBMET01639 | DBMET01637 | |
| 0.347 | 0.013 | 0.429 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.39 0.009 DBMET01637 0.429 0.006 DBMET01638 0.244 0.045 DBMET01639 | DBMET01638 | |
| 0.444 | 0.113 | 0.625 | Antiinflammatory | 0.576 0.06 DBMET01637 0.625 0.047 DBMET01638 0.347 0.174 DBMET01639 | DBMET01638 | |
| 0.336 | 0.013 | 0.427 | Protein kinase stimulant | 0.427 0.007 DBMET01637 0.328 0.014 DBMET01638 0.201 0.041 DBMET01639 | DBMET01637 | |
| 0.341 | 0.02 | 0.397 | Hepatoprotectant | 0.397 0.013 DBMET01637 0.258 0.041 DBMET01638 0.191 0.071 DBMET01639 | DBMET01637 | |
| 0.329 | 0.009 | 0.577 | Aldehyde dehydrogenase inhibitor | 0.577 0.004 DBMET01637 0.31 0.011 DBMET01638 0.153 0.045 DBMET01639 | DBMET01637 | |
| 0.323 | 0.005 | 0.374 | GABA C receptor rho-2 antagonist | 0.374 0.004 DBMET01637 0.315 0.005 DBMET01638 0.199 0.029 DBMET01639 | DBMET01637 | |
| 0.396 | 0.079 | 0.467 | Antibacterial | 0.467 0.051 DBMET01637 0.458 0.054 DBMET01638 0.413 0.071 DBMET01639 | DBMET01637 | |
| 0.343 | 0.025 | 0.417 | RNA-directed DNA polymerase inhibitor | 0.417 0.016 DBMET01637 0.319 0.028 DBMET01638 0.216 0.078 DBMET01639 | DBMET01637 | |
| 0.336 | 0.023 | 0.383 | Dual specificity phosphatase 3 inhibitor | 0.383 0.016 DBMET01637 0.312 0.027 DBMET01638 | DBMET01637 | |
| 0.383 | 0.071 | 0.409 | Immunosuppressant | 0.409 0.059 DBMET01637 0.309 0.109 DBMET01639 | DBMET01637 | |
| 0.321 | 0.013 | 0.467 | Neurotrophic factor enhancer | 0.339 0.01 DBMET01637 0.467 0.004 DBMET01638 0.267 0.03 DBMET01639 | DBMET01638 | |
| 0.336 | 0.034 | 0.336 | Psychostimulant | 0.279 0.049 DBMET01637 0.185 0.089 DBMET01638 0.166 0.103 DBMET01639 | ||
| 0.314 | 0.015 | 0.314 | Alpha-N-acetylglucosaminidase inhibitor | 0.314 0.015 DBMET01637 0.314 0.015 DBMET01638 0.237 0.025 DBMET01639 | ||
| 0.324 | 0.027 | 0.358 | Platelet adhesion inhibitor | 0.358 0.018 DBMET01637 0.133 0.128 DBMET01639 | DBMET01637 | |
| 0.331 | 0.043 | 0.464 | Hypoglycemic | 0.464 0.019 DBMET01637 0.182 0.131 DBMET01638 | DBMET01637 | |
| 0.326 | 0.043 | 0.362 | Transcription factor STAT inhibitor | 0.362 0.03 DBMET01637 0.232 0.101 DBMET01638 | DBMET01637 | |
| 0.402 | 0.119 | 0.484 | DNA polymerase beta inhibitor | 0.387 0.125 DBMET01637 0.484 0.091 DBMET01638 | DBMET01638 | |
| 0.36 | 0.082 | 0.36 | Calpain 2 inhibitor | 0.266 0.138 DBMET01637 | ||
| 0.278 | 0.004 | 0.32 | Carbonic anhydrase VB inhibitor | 0.32 0.003 DBMET01637 0.167 0.007 DBMET01638 0.077 0.024 DBMET01639 | DBMET01637 | |
| 0.336 | 0.062 | 0.47 | 12-Lipoxygenase inhibitor | 0.47 0.025 DBMET01637 0.394 0.041 DBMET01638 | DBMET01637 | |
| 0.299 | 0.029 | 0.355 | Dual specificity phosphatase inhibitor | 0.355 0.02 DBMET01637 0.285 0.031 DBMET01638 | DBMET01637 | |
| 0.314 | 0.05 | 0.334 | Insulysin inhibitor | 0.334 0.04 DBMET01637 0.318 0.048 DBMET01638 0.207 0.146 DBMET01639 | DBMET01637 | |
| 0.328 | 0.066 | 0.328 | Calcium channel activator | 0.308 0.084 DBMET01637 0.306 0.086 DBMET01638 0.279 0.114 DBMET01639 | ||
| 0.289 | 0.03 | 0.3 | DNA methyltransferase I inhibitor | 0.296 0.028 DBMET01637 0.3 0.026 DBMET01638 | DBMET01638 | |
| 0.272 | 0.016 | 0.309 | Succinate dehydrogenase inhibitor | 0.302 0.01 DBMET01637 0.309 0.009 DBMET01638 0.235 0.028 DBMET01639 | DBMET01638 | |
| 0.259 | 0.008 | 0.439 | Beta glucuronidase inhibitor | 0.439 0.004 DBMET01637 0.197 0.013 DBMET01638 0.109 0.057 DBMET01639 | DBMET01637 | |
| 0.29 | 0.04 | 0.29 | Gastrin inhibitor | 0.24 0.091 DBMET01637 0.223 0.114 DBMET01638 0.214 0.128 DBMET01639 | ||
| 0.255 | 0.005 | 0.255 | Chymotrypsin inhibitor | 0.168 0.013 DBMET01637 0.078 0.056 DBMET01638 | ||
| 0.254 | 0.004 | 0.306 | Carbonic anhydrase V inhibitor | 0.306 0.004 DBMET01637 0.166 0.011 DBMET01638 0.077 0.037 DBMET01639 | DBMET01637 | |
| 0.285 | 0.038 | 0.293 | ErbB-1 antagonist | 0.23 0.063 DBMET01637 0.293 0.035 DBMET01638 0.174 0.125 DBMET01639 | DBMET01638 | |
| 0.299 | 0.054 | 0.324 | Transcription factor STAT3 inhibitor | 0.324 0.043 DBMET01637 0.214 0.117 DBMET01638 | DBMET01637 | |
| 0.372 | 0.128 | 0.474 | DNA directed DNA polymerase inhibitor | 0.37 0.129 DBMET01637 0.474 0.09 DBMET01638 | DBMET01638 | |
| 0.265 | 0.023 | 0.317 | Nitric-oxide synthase stimulant | 0.317 0.008 DBMET01637 0.286 0.015 DBMET01638 0.227 0.052 DBMET01639 | DBMET01637 | |
| 0.256 | 0.014 | 0.256 | 5 Hydroxytryptamine 3E antagonist | 0.187 0.089 DBMET01637 0.21 0.048 DBMET01638 0.21 0.048 DBMET01639 | ||
| 0.258 | 0.017 | 0.258 | Interleukin 1 antagonist | 0.224 0.025 DBMET01637 | ||
| 0.292 | 0.054 | 0.422 | Antiamyloidogenic | 0.422 0.025 DBMET01637 0.27 0.062 DBMET01638 | DBMET01637 | |
| 0.26 | 0.023 | 0.359 | Topoisomerase II inhibitor | 0.359 0.013 DBMET01637 0.229 0.028 DBMET01638 | DBMET01637 | |
| 0.273 | 0.037 | 0.28 | DNA methylase inhibitor | 0.274 0.037 DBMET01637 0.28 0.034 DBMET01638 | DBMET01638 | |
| 0.248 | 0.014 | 0.253 | ATPase inhibitor | 0.253 0.013 DBMET01637 0.221 0.024 DBMET01638 0.205 0.033 DBMET01639 | DBMET01637 | |
| 0.246 | 0.014 | 0.246 | GABA C receptor agonist | 0.241 0.014 DBMET01637 0.241 0.014 DBMET01638 0.143 0.037 DBMET01639 | ||
| 0.281 | 0.052 | 0.391 | Interleukin antagonist | 0.391 0.032 DBMET01637 | DBMET01637 | |
| 0.248 | 0.023 | 0.299 | Interleukin 6 antagonist | 0.265 0.02 DBMET01637 0.155 0.081 DBMET01638 0.299 0.015 DBMET01639 | DBMET01639 | |
| 0.262 | 0.038 | 0.305 | Non-steroidal antiinflammatory agent | 0.286 0.031 DBMET01637 0.305 0.027 DBMET01638 | DBMET01638 | |
| 0.244 | 0.021 | 0.31 | Alkaline phosphatase inhibitor | 0.31 0.011 DBMET01637 0.215 0.028 DBMET01638 | DBMET01637 | |
| 0.251 | 0.032 | 0.258 | Amyloid beta precursor protein antagonist | 0.258 0.03 DBMET01637 0.225 0.043 DBMET01638 | DBMET01637 | |
| 0.23 | 0.014 | 0.398 | Xanthine oxidase inhibitor | 0.398 0.005 DBMET01637 0.279 0.009 DBMET01638 | DBMET01637 | |
| 0.232 | 0.019 | 0.597 | 5-Lipoxygenase inhibitor | 0.319 0.009 DBMET01637 0.597 0.004 DBMET01638 | DBMET01638 | |
| 0.227 | 0.014 | 0.227 | Interleukin 1b antagonist | 0.176 0.026 DBMET01637 | ||
| 0.217 | 0.004 | 0.258 | Carbonic anhydrase VA inhibitor | 0.258 0.004 DBMET01637 0.146 0.012 DBMET01638 0.08 0.036 DBMET01639 | DBMET01637 | |
| 0.275 | 0.063 | 0.316 | Tumour necrosis factor alpha release inhibitor | 0.316 0.048 DBMET01637 0.179 0.127 DBMET01638 0.307 0.05 DBMET01639 | DBMET01637 | |
| 0.302 | 0.09 | 0.346 | Cholesterol antagonist | 0.339 0.069 DBMET01637 0.346 0.066 DBMET01638 0.28 0.104 DBMET01639 | DBMET01638 | |
| 0.24 | 0.028 | 0.309 | Cyclooxygenase inhibitor | 0.242 0.028 DBMET01637 0.309 0.016 DBMET01638 | DBMET01638 | |
| 0.216 | 0.006 | 0.246 | GABA C receptor rho-1 antagonist | 0.246 0.004 DBMET01637 0.206 0.007 DBMET01638 0.126 0.035 DBMET01639 | DBMET01637 | |
| 0.257 | 0.047 | 0.287 | Anesthetic general | 0.287 0.036 DBMET01637 0.225 0.062 DBMET01638 0.136 0.13 DBMET01639 | DBMET01637 | |
| 0.217 | 0.008 | 0.412 | Creatine kinase inhibitor | 0.412 0.003 DBMET01637 0.306 0.004 DBMET01638 0.154 0.022 DBMET01639 | DBMET01637 | |
| 0.265 | 0.058 | 0.284 | DNA synthesis inhibitor | 0.284 0.049 DBMET01637 0.241 0.073 DBMET01638 0.21 0.108 DBMET01639 | DBMET01637 | |
| 0.216 | 0.01 | 0.266 | GABA C receptor antagonist | 0.266 0.005 DBMET01637 0.221 0.009 DBMET01638 0.149 0.03 DBMET01639 | DBMET01637 | |
| 0.213 | 0.008 | 0.251 | Carbonic anhydrase XII inhibitor | 0.251 0.006 DBMET01637 0.074 0.027 DBMET01638 | DBMET01637 | |
| 0.265 | 0.061 | 0.333 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.333 0.039 DBMET01637 | DBMET01637 | |
| 0.221 | 0.02 | 0.247 | Catenin beta inhibitor | 0.247 0.012 DBMET01637 0.146 0.115 DBMET01638 | DBMET01637 | |
| 0.204 | 0.003 | 0.204 | Sirtuin 2 inhibitor | 0.128 0.004 DBMET01637 0.099 0.004 DBMET01638 0.036 0.02 DBMET01639 | ||
| 0.302 | 0.101 | 0.302 | Thioredoxin glutathione reductase inhibitor | 0.219 0.156 DBMET01637 | ||
| 0.224 | 0.025 | 0.283 | Cyclooxygenase 2 inhibitor | 0.205 0.029 DBMET01637 0.283 0.015 DBMET01638 | DBMET01638 | |
| 0.203 | 0.011 | 0.227 | Phosphofructokinase-1 inhibitor | 0.227 0.009 DBMET01637 0.151 0.018 DBMET01638 0.124 0.024 DBMET01639 | DBMET01637 | |
| 0.22 | 0.029 | 0.476 | Monophenol monooxygenase inhibitor | 0.476 0.008 DBMET01637 0.39 0.012 DBMET01638 0.111 0.068 DBMET01639 | DBMET01637 | |
| 0.199 | 0.008 | 0.391 | Macrophage migration inhibitory factor inhibitor | 0.391 0.004 DBMET01637 0.329 0.004 DBMET01638 0.111 0.029 DBMET01639 | DBMET01637 | |
| 0.197 | 0.008 | 0.21 | Carbonic anhydrase IX inhibitor | 0.21 0.008 DBMET01637 0.07 0.032 DBMET01638 | DBMET01637 | |
| 0.226 | 0.039 | 0.226 | Histone acetyltransferase inhibitor | 0.206 0.061 DBMET01637 0.176 0.106 DBMET01638 | ||
| 0.247 | 0.062 | 0.344 | Pyruvate kinase inhibitor | 0.344 0.036 DBMET01637 0.337 0.038 DBMET01638 | DBMET01637 | |
| 0.209 | 0.025 | 0.224 | Arachidonic acid antagonist | 0.212 0.023 DBMET01637 0.224 0.015 DBMET01638 0.215 0.02 DBMET01639 | DBMET01638 | |
| 0.204 | 0.021 | 0.204 | Ferrochelatase inhibitor | 0.137 0.044 DBMET01637 0.144 0.04 DBMET01638 0.123 0.052 DBMET01639 | ||
| 0.282 | 0.102 | 0.306 | Antithrombotic | 0.306 0.084 DBMET01637 0.271 0.11 DBMET01638 0.294 0.092 DBMET01639 | DBMET01637 | |
| 0.206 | 0.027 | 0.216 | Mannose-6-phosphate isomerase inhibitor | 0.213 0.024 DBMET01637 0.216 0.022 DBMET01638 0.16 0.057 DBMET01639 | DBMET01638 | |
| 0.249 | 0.072 | 0.307 | Dyrk kinase inhibitor | 0.307 0.05 DBMET01637 | DBMET01637 | |
| 0.217 | 0.04 | 0.217 | Cytidine deaminase inhibitor | 0.136 0.086 DBMET01637 | ||
| 0.226 | 0.05 | 0.271 | P-glycoprotein inhibitor | 0.271 0.035 DBMET01637 0.157 0.106 DBMET01638 | DBMET01637 | |
| 0.19 | 0.015 | 0.19 | Calcium antagonist | 0.102 0.046 DBMET01637 | ||
| 0.183 | 0.007 | 0.233 | Interleukin 12 antagonist | 0.233 0.005 DBMET01637 | DBMET01637 | |
| 0.32 | 0.144 | 0.32 | Transcription factor inhibitor | 0.271 0.172 DBMET01637 0.221 0.208 DBMET01638 | ||
| 0.174 | 0.003 | 0.174 | Exportin-1 inhibitor | 0.124 0.004 DBMET01637 0.097 0.01 DBMET01638 0.096 0.011 DBMET01639 | ||
| 0.188 | 0.018 | 0.188 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.157 0.025 DBMET01637 0.156 0.025 DBMET01638 0.15 0.026 DBMET01639 | ||
| 0.274 | 0.108 | 0.274 | Thyroid hormone antagonist | 0.249 0.124 DBMET01637 0.227 0.139 DBMET01638 | ||
| 0.177 | 0.012 | 0.2 | Carbonic anhydrase inhibitor | 0.2 0.009 DBMET01637 0.065 0.043 DBMET01638 | DBMET01637 | |
| 0.17 | 0.005 | 0.17 | Progesterone antagonist | 0.131 0.007 DBMET01637 0.061 0.014 DBMET01638 | ||
| 0.192 | 0.029 | 0.261 | Cholesterol synthesis inhibitor | 0.261 0.016 DBMET01637 0.238 0.019 DBMET01638 0.136 0.052 DBMET01639 | DBMET01637 | |
| 0.191 | 0.028 | 0.192 | DNA intercalator | 0.192 0.028 DBMET01637 | DBMET01637 | |
| 0.269 | 0.106 | 0.269 | Thyroid hormone beta antagonist | 0.233 0.129 DBMET01637 0.214 0.142 DBMET01638 | ||
| 0.179 | 0.016 | 0.179 | Telomerase inhibitor | 0.137 0.022 DBMET01637 0.07 0.052 DBMET01638 | ||
| 0.178 | 0.016 | 0.227 | Androgen antagonist | 0.227 0.011 DBMET01637 0.114 0.037 DBMET01638 | DBMET01637 | |
| 0.172 | 0.011 | 0.176 | Ca2+-transporting ATPase inhibitor | 0.174 0.01 DBMET01637 0.176 0.009 DBMET01638 0.17 0.013 DBMET01639 | DBMET01638 | |
| 0.166 | 0.005 | 0.194 | GABA aminotransferase inhibitor | 0.194 0.004 DBMET01637 0.111 0.02 DBMET01638 0.072 0.059 DBMET01639 | DBMET01637 | |
| 0.201 | 0.042 | 0.241 | Phospholipase A2 inhibitor | 0.241 0.026 DBMET01637 0.161 0.065 DBMET01638 | DBMET01637 | |
| 0.182 | 0.024 | 0.241 | Microtubule formation inhibitor | 0.172 0.028 DBMET01637 0.137 0.045 DBMET01638 0.241 0.011 DBMET01639 | DBMET01639 | |
| 0.161 | 0.005 | 0.254 | Carbonic anhydrase VII inhibitor | 0.254 0.004 DBMET01637 0.068 0.016 DBMET01638 | DBMET01637 | |
| 0.177 | 0.022 | 0.192 | UDP-glucose 4-epimerase inhibitor | 0.192 0.019 DBMET01637 0.191 0.019 DBMET01638 0.16 0.026 DBMET01639 | DBMET01637 | |
| 0.157 | 0.006 | 0.157 | Caspase 7 inhibitor | 0.138 0.009 DBMET01637 0.091 0.041 DBMET01638 | ||
| 0.164 | 0.013 | 0.167 | Interleukin 1 beta converting enzyme inhibitor | 0.167 0.012 DBMET01637 0.119 0.036 DBMET01638 | DBMET01637 | |
| 0.196 | 0.046 | 0.196 | Diuretic | 0.19 0.048 DBMET01637 0.149 0.078 DBMET01638 | ||
| 0.18 | 0.03 | 0.335 | Interleukin 4 antagonist | 0.335 0.007 DBMET01637 0.252 0.013 DBMET01638 | DBMET01637 | |
| 0.164 | 0.015 | 0.227 | DOPA decarboxylase inhibitor | 0.227 0.004 DBMET01637 0.209 0.005 DBMET01638 0.123 0.042 DBMET01639 | DBMET01637 | |
| 0.154 | 0.005 | 0.154 | Aryl hydrocarbon receptor antagonist | 0.123 0.007 DBMET01637 0.081 0.025 DBMET01638 | ||
| 0.168 | 0.019 | 0.191 | Heat shock protein 70 antagonist | 0.191 0.008 DBMET01637 0.175 0.014 DBMET01638 0.14 0.075 DBMET01639 | DBMET01637 | |
| 0.159 | 0.011 | 0.172 | CDC25A inhibitor | 0.172 0.01 DBMET01637 0.133 0.016 DBMET01638 0.072 0.053 DBMET01639 | DBMET01637 | |
| 0.165 | 0.019 | 0.165 | Sphingosine 1-phosphate receptor 2 agonist | 0.155 0.023 DBMET01637 0.149 0.026 DBMET01638 | ||
| 0.167 | 0.022 | 0.214 | Papain-like protease (SARS coronavirus) inhibitor | 0.214 0.008 DBMET01637 0.174 0.018 DBMET01638 0.153 0.032 DBMET01639 | DBMET01637 | |
| 0.157 | 0.012 | 0.224 | Aromatase inhibitor | 0.224 0.007 DBMET01637 0.093 0.023 DBMET01638 0.076 0.03 DBMET01639 | DBMET01637 | |
| 0.235 | 0.091 | 0.235 | 5 Hydroxytryptamine 1E antagonist | 0.194 0.138 DBMET01637 0.222 0.106 DBMET01638 | ||
| 0.149 | 0.005 | 0.301 | Carbonic anhydrase XIV inhibitor | 0.301 0.004 DBMET01637 0.102 0.01 DBMET01638 | DBMET01637 | |
| 0.148 | 0.004 | 0.148 | Potassium channel Kv1.3 blocker | 0.133 0.005 DBMET01637 0.067 0.017 DBMET01638 0.045 0.035 DBMET01639 | ||
| 0.147 | 0.004 | 0.147 | Potassium channel intermediate-conductance Ca-activated blocker | 0.07 0.027 DBMET01637 0.061 0.039 DBMET01638 0.056 0.051 DBMET01639 | ||
| 0.157 | 0.017 | 0.157 | Electrolyte absorption antagonist | 0.115 0.04 DBMET01637 0.14 0.024 DBMET01638 0.098 0.06 DBMET01639 | ||
| 0.185 | 0.048 | 0.279 | Interferon gamma antagonist | 0.234 0.032 DBMET01637 0.279 0.023 DBMET01638 0.252 0.028 DBMET01639 | DBMET01638 | |
| 0.155 | 0.019 | 0.155 | Triose-phosphate isomerase inhibitor | 0.147 0.021 DBMET01637 0.143 0.022 DBMET01638 0.117 0.034 DBMET01639 | ||
| 0.21 | 0.076 | 0.231 | MAP kinase kinase 2 inhibitor | 0.231 0.063 DBMET01637 | DBMET01637 | |
| 0.169 | 0.036 | 0.189 | Adenylate cyclase stimulant | 0.181 0.025 DBMET01637 0.189 0.019 DBMET01638 0.149 0.065 DBMET01639 | DBMET01638 | |
| 0.167 | 0.035 | 0.178 | Antibacterial (Helicobacter pylori) | 0.178 0.029 DBMET01637 | DBMET01637 | |
| 0.191 | 0.059 | 0.24 | Tumour necrosis factor antagonist | 0.197 0.055 DBMET01637 0.24 0.034 DBMET01638 | DBMET01638 | |
| 0.185 | 0.053 | 0.265 | Protein-tyrosine phosphatase inhibitor | 0.265 0.027 DBMET01637 0.208 0.044 DBMET01638 0.231 0.036 DBMET01639 | DBMET01637 | |
| 0.156 | 0.026 | 0.162 | DNA repair enzyme inhibitor | 0.162 0.022 DBMET01637 0.144 0.037 DBMET01638 | DBMET01637 | |
| 0.156 | 0.027 | 0.167 | TRPA1 agonist | 0.167 0.021 DBMET01637 0.166 0.021 DBMET01638 0.106 0.077 DBMET01639 | DBMET01637 | |
| 0.149 | 0.021 | 0.193 | Porphobilinogen synthase inhibitor | 0.193 0.013 DBMET01637 0.183 0.014 DBMET01638 0.068 0.058 DBMET01639 | DBMET01637 | |
| 0.14 | 0.011 | 0.184 | Histone deacetylase stimulant | 0.184 0.005 DBMET01637 | DBMET01637 | |
| 0.14 | 0.011 | 0.184 | Histone deacetylase SIRT1 stimulant | 0.184 0.005 DBMET01637 | DBMET01637 | |
| 0.136 | 0.008 | 0.145 | Granulocyte macrophage colony stimulating factor agonist | 0.131 0.01 DBMET01637 0.145 0.006 DBMET01638 0.102 0.032 DBMET01639 | DBMET01638 | |
| 0.173 | 0.046 | 0.327 | Cyclooxygenase 1 inhibitor | 0.209 0.031 DBMET01637 0.327 0.011 DBMET01638 | DBMET01638 | |
| 0.2 | 0.073 | 0.248 | Insulin sensitizer | 0.224 0.052 DBMET01637 0.248 0.035 DBMET01638 0.185 0.09 DBMET01639 | DBMET01638 | |
| 0.15 | 0.025 | 0.185 | Multidrug resistance-associated protein 1 inhibitor | 0.185 0.014 DBMET01637 0.105 0.069 DBMET01638 | DBMET01637 | |
| 0.139 | 0.015 | 0.147 | Ornithine decarboxylase inhibitor | 0.147 0.012 DBMET01637 0.128 0.021 DBMET01638 0.093 0.053 DBMET01639 | DBMET01637 | |
| 0.164 | 0.041 | 0.164 | Sphingosine 1-phosphate receptor 5 antagonist | 0.148 0.065 DBMET01637 0.16 0.046 DBMET01638 | ||
| 0.165 | 0.043 | 0.208 | Toll-Like receptor 2 antagonist | 0.199 0.024 DBMET01637 0.208 0.02 DBMET01638 0.116 0.082 DBMET01639 | DBMET01638 | |
| 0.159 | 0.038 | 0.242 | Topoisomerase I inhibitor | 0.242 0.018 DBMET01637 0.174 0.033 DBMET01638 | DBMET01637 | |
| 0.148 | 0.027 | 0.148 | Adenylate kinase inhibitor | 0.136 0.033 DBMET01637 0.141 0.03 DBMET01638 0.116 0.047 DBMET01639 | ||
| 0.153 | 0.034 | 0.153 | 5 Hydroxytryptamine 3A agonist | 0.106 0.069 DBMET01637 0.135 0.045 DBMET01638 | ||
| 0.145 | 0.027 | 0.156 | Transcription factor STAT6 inhibitor | 0.156 0.019 DBMET01637 0.148 0.025 DBMET01638 | DBMET01637 | |
| 0.206 | 0.089 | 0.233 | Cyclic AMP phosphodiesterase inhibitor | 0.217 0.082 DBMET01637 0.233 0.073 DBMET01638 0.169 0.124 DBMET01639 | DBMET01638 | |
| 0.158 | 0.042 | 0.197 | Cyclooxygenase 3 inhibitor | 0.184 0.026 DBMET01637 0.197 0.02 DBMET01638 0.126 0.071 DBMET01639 | DBMET01638 | |
| 0.129 | 0.015 | 0.181 | ATPase (Vacuolar H+) inhibitor | 0.118 0.021 DBMET01637 0.181 0.004 DBMET01638 0.108 0.03 DBMET01639 | DBMET01638 | |
| 0.127 | 0.014 | 0.127 | mTOR complex 2 inhibitor | 0.112 0.022 DBMET01637 0.121 0.017 DBMET01638 0.118 0.019 DBMET01639 | ||
| 0.147 | 0.036 | 0.147 | Sphingosine 1-phosphate receptor 4 antagonist | 0.11 0.094 DBMET01637 0.133 0.051 DBMET01638 | ||
| 0.162 | 0.052 | 0.162 | Histone deacetylase SIRT1 inhibitor | 0.152 0.06 DBMET01637 | ||
| 0.114 | 0.005 | 0.114 | Glutamate (mGluR7) antagonist | 0.105 0.009 DBMET01637 0.106 0.008 DBMET01638 0.109 0.007 DBMET01639 | ||
| 0.136 | 0.027 | 0.136 | Interleukin 2 antagonist | 0.113 0.056 DBMET01637 0.106 0.072 DBMET01639 | ||
| 0.112 | 0.004 | 0.112 | DNA gyrase subunit A inhibitor | 0.091 0.004 DBMET01637 0.071 0.006 DBMET01638 0.049 0.018 DBMET01639 | ||
| 0.121 | 0.014 | 0.217 | Aldose reductase inhibitor | 0.217 0.006 DBMET01637 0.165 0.009 DBMET01638 | DBMET01637 | |
| 0.21 | 0.104 | 0.21 | Calpain inhibitor | 0.169 0.15 DBMET01637 | ||
| 0.126 | 0.02 | 0.232 | Keratolytic | 0.232 0.006 DBMET01637 0.136 0.017 DBMET01638 0.071 0.064 DBMET01639 | DBMET01637 | |
| 0.11 | 0.004 | 0.134 | Dopamine autoreceptor agonist | 0.134 0.004 DBMET01637 0.038 0.01 DBMET01638 | DBMET01637 | |
| 0.216 | 0.111 | 0.289 | Immunostimulant | 0.289 0.082 DBMET01637 0.218 0.11 DBMET01638 | DBMET01637 | |
| 0.108 | 0.004 | 0.108 | Glucose-6-phosphate isomerase inhibitor | 0.107 0.004 DBMET01637 0.08 0.009 DBMET01638 0.068 0.013 DBMET01639 | ||
| 0.131 | 0.027 | 0.244 | Topoisomerase II alpha inhibitor | 0.244 0.01 DBMET01637 0.203 0.014 DBMET01638 | DBMET01637 | |
| 0.16 | 0.057 | 0.16 | Toll-Like receptor 9 antagonist | 0.141 0.069 DBMET01637 | ||
| 0.208 | 0.105 | 0.208 | Neuropeptide Y2 antagonist | 0.203 0.114 DBMET01637 | ||
| 0.158 | 0.056 | 0.158 | Cytokine production inhibitor | 0.125 0.085 DBMET01637 | ||
| 0.137 | 0.035 | 0.218 | Mediator release inhibitor | 0.177 0.019 DBMET01637 0.218 0.012 DBMET01638 | DBMET01638 | |
| 0.129 | 0.027 | 0.147 | MAP kinase kinase 1 inhibitor | 0.147 0.018 DBMET01637 0.085 0.078 DBMET01638 | DBMET01637 | |
| 0.147 | 0.046 | 0.147 | Histone deacetylase class III inhibitor | 0.126 0.064 DBMET01637 | ||
| 0.111 | 0.011 | 0.138 | Androgen agonist | 0.138 0.008 DBMET01637 0.107 0.012 DBMET01638 0.058 0.044 DBMET01639 | DBMET01637 | |
| 0.126 | 0.026 | 0.145 | NADH dehydrogenase inhibitor | 0.144 0.019 DBMET01637 0.145 0.019 DBMET01638 0.114 0.032 DBMET01639 | DBMET01638 | |
| 0.114 | 0.015 | 0.241 | Alcohol oxidase inhibitor | 0.241 0.005 DBMET01637 0.152 0.01 DBMET01638 0.065 0.032 DBMET01639 | DBMET01637 | |
| 0.152 | 0.053 | 0.238 | NADPH oxidase inhibitor | 0.238 0.024 DBMET01637 0.204 0.033 DBMET01638 | DBMET01637 | |
| 0.123 | 0.025 | 0.317 | Histidine decarboxylase inhibitor | 0.317 0.005 DBMET01637 0.199 0.013 DBMET01638 0.101 0.031 DBMET01639 | DBMET01637 | |
| 0.105 | 0.008 | 0.105 | Aldosterone antagonist | 0.046 0.035 DBMET01637 0.044 0.039 DBMET01638 | ||
| 0.114 | 0.017 | 0.15 | D-Ala-D-Ala ligase inhibitor | 0.15 0.005 DBMET01637 0.139 0.007 DBMET01638 0.082 0.063 DBMET01639 | DBMET01637 | |
| 0.13 | 0.034 | 0.13 | Acetylcholine release stimulant | 0.108 0.07 DBMET01638 | ||
| 0.165 | 0.07 | 0.194 | Neurotensin receptor agonist | 0.194 0.038 DBMET01637 0.179 0.051 DBMET01638 | DBMET01637 | |
| 0.114 | 0.019 | 0.123 | Sphingosine 1-phosphate receptor 4 agonist | 0.123 0.016 DBMET01637 0.097 0.026 DBMET01638 | DBMET01637 | |
| 0.144 | 0.05 | 0.185 | Alkylator | 0.185 0.031 DBMET01637 0.144 0.05 DBMET01638 0.105 0.082 DBMET01639 | DBMET01637 | |
| 0.126 | 0.031 | 0.228 | Alcohol dehydrogenase inhibitor | 0.228 0.009 DBMET01637 0.168 0.016 DBMET01638 | DBMET01637 | |
| 0.136 | 0.042 | 0.155 | Mucolytic | 0.144 0.036 DBMET01637 0.155 0.03 DBMET01638 0.123 0.052 DBMET01639 | DBMET01638 | |
| 0.13 | 0.036 | 0.592 | Electron transport complex I inhibitor | 0.132 0.033 DBMET01637 0.592 0.002 DBMET01638 0.114 0.055 DBMET01639 | DBMET01638 | |
| 0.159 | 0.066 | 0.233 | Heat shock protein 90 antagonist | 0.233 0.026 DBMET01637 0.155 0.07 DBMET01638 0.17 0.056 DBMET01639 | DBMET01637 | |
| 0.113 | 0.02 | 0.2 | Phenylalanine 4-hydroxylase inhibitor | 0.178 0.008 DBMET01637 0.2 0.007 DBMET01638 0.076 0.04 DBMET01639 | DBMET01638 | |
| 0.142 | 0.052 | 0.142 | Sphingosine 1-phosphate receptor 2 antagonist | 0.129 0.077 DBMET01637 0.138 0.059 DBMET01638 | ||
| 0.167 | 0.077 | 0.202 | Phospholipase C inhibitor | 0.202 0.042 DBMET01637 0.188 0.053 DBMET01638 | DBMET01637 | |
| 0.125 | 0.035 | 0.142 | Anabolic | 0.142 0.022 DBMET01637 0.142 0.023 DBMET01638 0.106 0.055 DBMET01639 | DBMET01638 | |
| 0.099 | 0.009 | 0.099 | Aconitate hydratase inhibitor | 0.077 0.015 DBMET01637 0.083 0.013 DBMET01638 0.072 0.018 DBMET01639 | ||
| 0.12 | 0.03 | 0.12 | Glutamate (mGluR7) agonist | 0.089 0.086 DBMET01638 0.094 0.074 DBMET01639 | ||
| 0.134 | 0.045 | 0.134 | Aminopeptidase B inhibitor | 0.132 0.046 DBMET01637 0.131 0.047 DBMET01638 0.088 0.074 DBMET01639 | ||
| 0.125 | 0.037 | 0.188 | HIV-1 integrase (Overall Integration) inhibitor | 0.131 0.033 DBMET01637 0.188 0.014 DBMET01638 0.087 0.069 DBMET01639 | DBMET01638 | |
| 0.112 | 0.024 | 0.143 | Myeloperoxidase inhibitor | 0.143 0.012 DBMET01637 0.099 0.036 DBMET01638 | DBMET01637 | |
| 0.271 | 0.184 | 0.416 | Calcium channel L-type activator | 0.416 0.071 DBMET01637 0.345 0.121 DBMET01638 | DBMET01637 | |
| 0.096 | 0.009 | 0.096 | Oleamide hydrolase inhibitor | 0.061 0.02 DBMET01637 | ||
| 0.109 | 0.024 | 0.119 | Na+ K+ transporting ATPase inhibitor | 0.119 0.017 DBMET01637 0.095 0.036 DBMET01638 0.079 0.051 DBMET01639 | DBMET01637 | |
| 0.096 | 0.012 | 0.096 | Glutamate (mGluR6) antagonist | 0.082 0.022 DBMET01637 0.09 0.016 DBMET01638 0.086 0.019 DBMET01639 | ||
| 0.098 | 0.016 | 0.098 | Protease 3C (Human rhinovirus) inhibitor | 0.085 0.024 DBMET01637 0.071 0.036 DBMET01638 0.058 0.056 DBMET01639 | ||
| 0.113 | 0.032 | 0.114 | Phosphodiesterase 6D inhibitor | 0.111 0.034 DBMET01637 0.114 0.031 DBMET01638 | DBMET01638 | |
| 0.105 | 0.024 | 0.593 | HIV-1 integrase (3'-Processing) inhibitor | 0.209 0.009 DBMET01637 0.593 0.003 DBMET01638 0.084 0.032 DBMET01639 | DBMET01638 | |
| 0.104 | 0.025 | 0.104 | Thioredoxin reductase inhibitor | 0.094 0.035 DBMET01637 0.094 0.035 DBMET01638 0.099 0.03 DBMET01639 | ||
| 0.109 | 0.03 | 0.109 | Inducible nitric-oxide synthase inhibitor | 0.086 0.053 DBMET01637 | ||
| 0.157 | 0.079 | 0.218 | Heat shock protein 90 alpha antagonist | 0.218 0.04 DBMET01637 0.146 0.091 DBMET01638 | DBMET01637 | |
| 0.199 | 0.121 | 0.199 | Interleukin agonist | 0.196 0.124 DBMET01637 0.198 0.122 DBMET01638 | ||
| 0.083 | 0.005 | 0.129 | Dopamine D5 agonist | 0.108 0.004 DBMET01637 0.129 0.003 DBMET01638 0.051 0.017 DBMET01639 | DBMET01638 | |
| 0.126 | 0.048 | 0.315 | Chelator | 0.315 0.01 DBMET01637 0.239 0.018 DBMET01638 | DBMET01637 | |
| 0.146 | 0.069 | 0.164 | Cell wall synthesis inhibitor | 0.164 0.053 DBMET01637 0.134 0.081 DBMET01638 | DBMET01637 | |
| 0.099 | 0.022 | 0.107 | Glycine receptor agonist | 0.099 0.021 DBMET01637 0.107 0.017 DBMET01638 0.093 0.025 DBMET01639 | DBMET01638 | |
| 0.102 | 0.025 | 0.118 | Leukotriene synthesis inhibitor | 0.118 0.018 DBMET01637 0.079 0.038 DBMET01638 0.073 0.042 DBMET01639 | DBMET01637 | |
| 0.108 | 0.031 | 0.108 | Factor XII inhibitor | 0.091 0.048 DBMET01637 | ||
| 0.083 | 0.007 | 0.093 | Ryanodine receptor antagonist | 0.08 0.009 DBMET01637 0.093 0.005 DBMET01638 0.059 0.041 DBMET01639 | DBMET01638 | |
| 0.116 | 0.04 | 0.346 | Antineoplastic antibiotic | 0.158 0.029 DBMET01637 0.095 0.048 DBMET01638 0.346 0.007 DBMET01639 | DBMET01639 | |
| 0.083 | 0.007 | 0.083 | Potassium channel (Inward rectifier) activator | 0.055 0.027 DBMET01637 0.055 0.027 DBMET01638 0.053 0.03 DBMET01639 | ||
| 0.13 | 0.055 | 0.217 | Protein-tyrosine phosphatase 1B inhibitor | 0.207 0.027 DBMET01637 0.161 0.041 DBMET01638 0.217 0.024 DBMET01639 | DBMET01639 | |
| 0.094 | 0.02 | 0.094 | NMDA receptor glycine site agonist | 0.066 0.04 DBMET01637 0.091 0.022 DBMET01638 | ||
| 0.102 | 0.029 | 0.146 | Glutamate decarboxylase inhibitor | 0.146 0.014 DBMET01637 0.119 0.021 DBMET01638 0.072 0.053 DBMET01639 | DBMET01637 | |
| 0.123 | 0.05 | 0.389 | Estrogen antagonist | 0.389 0.005 DBMET01637 0.201 0.013 DBMET01638 0.121 0.054 DBMET01639 | DBMET01637 | |
| 0.079 | 0.007 | 0.079 | Potassium channel (ATP-sensitive) activator | 0.052 0.026 DBMET01637 0.052 0.026 DBMET01638 0.05 0.029 DBMET01639 | ||
| 0.113 | 0.041 | 0.389 | Estrogen receptor beta antagonist | 0.389 0.004 DBMET01637 0.187 0.011 DBMET01638 0.116 0.037 DBMET01639 | DBMET01637 | |
| 0.101 | 0.031 | 0.136 | Glycine receptor antagonist | 0.086 0.048 DBMET01637 0.105 0.028 DBMET01638 0.136 0.011 DBMET01639 | DBMET01639 | |
| 0.119 | 0.049 | 0.148 | Protein kinase (CK2) inhibitor | 0.148 0.033 DBMET01637 0.107 0.058 DBMET01638 | DBMET01637 | |
| 0.171 | 0.103 | 0.554 | Antimitotic | 0.199 0.084 DBMET01637 0.554 0.009 DBMET01639 | DBMET01639 | |
| 0.092 | 0.023 | 0.092 | Carbamoyl phosphate synthetase inhibitor | 0.089 0.024 DBMET01637 0.089 0.024 DBMET01638 0.069 0.036 DBMET01639 | ||
| 0.075 | 0.009 | 0.075 | Cholesterol esterase inhibitor | 0.068 0.011 DBMET01637 0.048 0.033 DBMET01638 | ||
| 0.111 | 0.045 | 0.166 | Prolactin inhibitor | 0.166 0.016 DBMET01637 0.133 0.03 DBMET01638 | DBMET01637 | |
| 0.079 | 0.014 | 0.113 | Topoisomerase II beta inhibitor | 0.081 0.013 DBMET01637 0.113 0.008 DBMET01638 | DBMET01638 | |
| 0.127 | 0.063 | 0.205 | DNA polymerase I inhibitor | 0.205 0.027 DBMET01637 0.107 0.079 DBMET01638 | DBMET01637 | |
| 0.086 | 0.021 | 0.168 | Xanthine dehydrogenase inhibitor | 0.168 0.005 DBMET01637 0.123 0.01 DBMET01638 | DBMET01637 | |
| 0.09 | 0.026 | 0.102 | GABA B receptor agonist | 0.102 0.015 DBMET01637 0.097 0.019 DBMET01638 | DBMET01637 | |
| 0.087 | 0.023 | 0.087 | Biliverdin reductase inhibitor | 0.077 0.028 DBMET01637 0.077 0.028 DBMET01638 0.057 0.044 DBMET01639 | ||
| 0.095 | 0.032 | 0.12 | Estrogen-related receptor beta agonist | 0.12 0.01 DBMET01637 0.11 0.015 DBMET01638 0.078 0.073 DBMET01639 | DBMET01637 | |
| 0.069 | 0.007 | 0.069 | Cytokine production stimulant | 0.061 0.012 DBMET01637 | ||
| 0.127 | 0.066 | 0.127 | Cathepsin H inhibitor | 0.108 0.092 DBMET01639 | ||
| 0.084 | 0.023 | 0.09 | Carbonic anhydrase I inhibitor | 0.09 0.021 DBMET01637 | DBMET01637 | |
| 0.074 | 0.013 | 0.079 | Carbonic anhydrase IV inhibitor | 0.079 0.011 DBMET01637 | DBMET01637 | |
| 0.145 | 0.085 | 0.197 | CF transmembrane conductance regulator agonist | 0.197 0.023 DBMET01637 0.146 0.084 DBMET01638 | DBMET01637 | |
| 0.074 | 0.014 | 0.077 | Acetyl-CoA transferase 2 inhibitor | 0.064 0.024 DBMET01637 0.066 0.021 DBMET01638 0.077 0.013 DBMET01639 | DBMET01639 | |
| 0.114 | 0.055 | 0.141 | Expectorant | 0.137 0.041 DBMET01637 0.141 0.039 DBMET01638 0.131 0.044 DBMET01639 | DBMET01638 | |
| 0.13 | 0.071 | 0.135 | CC chemokine 6 receptor antagonist | 0.135 0.054 DBMET01637 | DBMET01637 | |
| 0.093 | 0.034 | 0.096 | Glutamate dehydrogenase inhibitor | 0.094 0.034 DBMET01637 0.096 0.033 DBMET01638 0.078 0.047 DBMET01639 | DBMET01638 | |
| 0.079 | 0.021 | 0.079 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.071 0.025 DBMET01637 0.076 0.022 DBMET01638 0.061 0.033 DBMET01639 | ||
| 0.065 | 0.007 | 0.165 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.165 0.003 DBMET01637 0.066 0.007 DBMET01638 | DBMET01637 | |
| 0.194 | 0.137 | 0.273 | Streptokinase A inhibitor | 0.273 0.091 DBMET01637 | DBMET01637 | |
| 0.215 | 0.159 | 0.224 | Vasodilator, peripheral | 0.206 0.169 DBMET01637 0.224 0.15 DBMET01638 | DBMET01638 | |
| 0.105 | 0.049 | 0.113 | Lanosterol 14 alpha demethylase inhibitor | 0.113 0.039 DBMET01637 0.096 0.062 DBMET01638 | DBMET01637 | |
| 0.071 | 0.015 | 0.223 | Estradiol 17 beta-dehydrogenase inhibitor | 0.223 0.004 DBMET01637 0.107 0.01 DBMET01638 | DBMET01637 | |
| 0.076 | 0.021 | 0.084 | Transcription factor RelA inhibitor | 0.084 0.014 DBMET01637 0.079 0.018 DBMET01638 0.063 0.045 DBMET01639 | DBMET01637 | |
| 0.164 | 0.109 | 0.164 | Focal adhesion kinase 2 inhibitor | |||
| 0.107 | 0.052 | 0.107 | Sphingomyelinase inhibitor | 0.094 0.067 DBMET01637 0.089 0.073 DBMET01638 0.088 0.075 DBMET01639 | ||
| 0.079 | 0.025 | 0.096 | Purinergic P2X1 antagonist | 0.081 0.024 DBMET01637 0.096 0.018 DBMET01638 0.061 0.042 DBMET01639 | DBMET01638 | |
| 0.095 | 0.04 | 0.131 | Catalase inhibitor | 0.088 0.043 DBMET01637 0.131 0.03 DBMET01638 | DBMET01638 | |
| 0.085 | 0.032 | 0.085 | Vanilloid 4 agonist | 0.073 0.056 DBMET01638 | ||
| 0.134 | 0.08 | 0.368 | Lipid peroxidase inhibitor | 0.319 0.016 DBMET01637 0.368 0.011 DBMET01638 | DBMET01638 | |
| 0.089 | 0.036 | 0.171 | Estrogen receptor alpha antagonist | 0.171 0.01 DBMET01637 0.126 0.017 DBMET01638 0.079 0.051 DBMET01639 | DBMET01637 | |
| 0.105 | 0.052 | 0.105 | Nitric-oxide synthase inhibitor | |||
| 0.068 | 0.016 | 0.103 | CD45 antagonist | 0.096 0.009 DBMET01637 0.103 0.009 DBMET01638 | DBMET01638 | |
| 0.056 | 0.005 | 0.056 | Glutamate (mGluR1a) agonist | 0.023 0.014 DBMET01637 0.036 0.006 DBMET01638 0.021 0.016 DBMET01639 | ||
| 0.062 | 0.011 | 0.077 | Nicotinic acid receptor 2 agonist | 0.077 0.008 DBMET01637 | DBMET01637 | |
| 0.061 | 0.011 | 0.061 | GABA B receptor antagonist | 0.056 0.014 DBMET01637 0.053 0.017 DBMET01638 | ||
| 0.082 | 0.033 | 0.082 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.072 0.054 DBMET01638 | ||
| 0.055 | 0.006 | 0.094 | ATP citrate lysase inhibitor | 0.094 0.004 DBMET01637 0.063 0.005 DBMET01638 0.042 0.011 DBMET01639 | DBMET01637 | |
| 0.081 | 0.032 | 0.081 | Dopamine D4 antagonist | 0.052 0.048 DBMET01637 | ||
| 0.092 | 0.045 | 0.092 | Hematopoietic | 0.087 0.055 DBMET01637 | ||
| 0.108 | 0.061 | 0.149 | AMP-activated protein kinase stimulant | 0.149 0.029 DBMET01637 0.133 0.039 DBMET01638 | DBMET01637 | |
| 0.116 | 0.069 | 0.117 | Proteasome inhibitor | 0.117 0.068 DBMET01637 0.1 0.087 DBMET01638 | DBMET01637 | |
| 0.074 | 0.028 | 0.074 | Argininosuccinate synthase inhibitor | 0.063 0.034 DBMET01637 0.068 0.031 DBMET01638 0.049 0.048 DBMET01639 | ||
| 0.072 | 0.026 | 0.072 | Acyl-CoA dehydrogenase inhibitor | 0.062 0.031 DBMET01637 0.062 0.031 DBMET01638 0.049 0.044 DBMET01639 | ||
| 0.064 | 0.018 | 0.073 | Squalene epoxidase inhibitor | 0.073 0.012 DBMET01637 0.065 0.017 DBMET01638 0.049 0.036 DBMET01639 | DBMET01637 | |
| 0.106 | 0.06 | 0.135 | Urease inhibitor | 0.135 0.032 DBMET01637 0.115 0.05 DBMET01638 | DBMET01637 | |
| 0.057 | 0.012 | 0.057 | Nerve growth factor antagonist | 0.039 0.037 DBMET01637 0.054 0.014 DBMET01638 | ||
| 0.083 | 0.039 | 0.083 | Aminopeptidase I inhibitor | 0.082 0.04 DBMET01637 0.079 0.043 DBMET01638 0.065 0.061 DBMET01639 | ||
| 0.07 | 0.026 | 0.117 | Fatty acid synthase inhibitor | 0.096 0.012 DBMET01637 0.117 0.007 DBMET01638 0.099 0.011 DBMET01639 | DBMET01638 | |
| 0.076 | 0.032 | 0.076 | NMDA receptor agonist | 0.058 0.05 DBMET01637 0.074 0.033 DBMET01638 | ||
| 0.115 | 0.071 | 0.115 | Anesthetic local | |||
| 0.07 | 0.028 | 0.07 | Kallikrein 7 inhibitor | 0.059 0.058 DBMET01638 | ||
| 0.06 | 0.018 | 0.06 | Adenylate cyclase 1 inhibitor | 0.043 0.036 DBMET01637 0.055 0.022 DBMET01638 | ||
| 0.075 | 0.033 | 0.506 | HIV-1 integrase (Strand Transfer) inhibitor | 0.169 0.011 DBMET01637 0.506 0.003 DBMET01638 0.054 0.046 DBMET01639 | DBMET01638 | |
| 0.093 | 0.051 | 0.093 | Bromodomain-containing protein 2 inhibitor | |||
| 0.073 | 0.031 | 0.073 | MDM2 inhibitor | 0.066 0.053 DBMET01638 0.065 0.057 DBMET01639 | ||
| 0.097 | 0.056 | 0.111 | Bile acid receptor antagonist | 0.111 0.03 DBMET01637 0.108 0.034 DBMET01638 | DBMET01637 | |
| 0.086 | 0.045 | 0.086 | Transforming growth factor beta 3 antagonist | |||
| 0.12 | 0.08 | 0.331 | Tubulin antagonist | 0.173 0.047 DBMET01637 0.13 0.071 DBMET01638 0.331 0.016 DBMET01639 | DBMET01639 | |
| 0.094 | 0.054 | 0.094 | Glutamate release inhibitor | 0.087 0.07 DBMET01637 0.085 0.076 DBMET01638 0.091 0.06 DBMET01639 | ||
| 0.07 | 0.031 | 0.121 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.121 0.012 DBMET01637 0.104 0.016 DBMET01638 | DBMET01637 | |
| 0.041 | 0.005 | 0.041 | Nicotinic acid receptor 2 antagonist | 0.035 0.008 DBMET01637 0.03 0.013 DBMET01638 | ||
| 0.131 | 0.096 | 0.131 | Pregnane X receptor agonist | |||
| 0.049 | 0.015 | 0.049 | Retinoid X alpha receptor agonist | 0.041 0.019 DBMET01637 0.048 0.015 DBMET01638 | ||
| 0.086 | 0.053 | 0.1 | Glutathione S-transferase inhibitor | 0.1 0.037 DBMET01637 0.084 0.056 DBMET01638 | DBMET01637 | |
| 0.049 | 0.016 | 0.058 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.058 0.009 DBMET01637 0.057 0.009 DBMET01638 | DBMET01637 | |
| 0.078 | 0.045 | 0.082 | Cathepsin G inhibitor | 0.082 0.043 DBMET01637 0.068 0.056 DBMET01638 | DBMET01637 | |
| 0.044 | 0.012 | 0.046 | Tubulin agonist | 0.046 0.01 DBMET01637 0.038 0.018 DBMET01639 | DBMET01637 | |
| 0.051 | 0.019 | 0.051 | Guanylate cyclase inhibitor | 0.041 0.031 DBMET01637 0.041 0.032 DBMET01638 | ||
| 0.047 | 0.015 | 0.047 | Retinoid X receptor antagonist | 0.044 0.019 DBMET01637 0.046 0.016 DBMET01638 | ||
| 0.06 | 0.028 | 0.061 | Dihydroorotate oxidase inhibitor | 0.061 0.027 DBMET01637 0.059 0.03 DBMET01638 | DBMET01637 | |
| 0.057 | 0.026 | 0.057 | Potassium channel (Inward rectifier) blocker | |||
| 0.046 | 0.015 | 0.046 | Glutamate (mGluR8) agonist | 0.043 0.018 DBMET01637 0.045 0.016 DBMET01638 0.038 0.026 DBMET01639 | ||
| 0.109 | 0.079 | 0.109 | Beta amyloid protein antagonist | 0.096 0.095 DBMET01638 | ||
| 0.058 | 0.027 | 0.058 | Heparanase inhibitor | 0.055 0.033 DBMET01638 0.053 0.038 DBMET01639 | ||
| 0.067 | 0.037 | 0.067 | Nitric oxide donor | 0.067 0.037 DBMET01637 | ||
| 0.041 | 0.012 | 0.044 | Protein kinase (CK2) beta inhibitor | 0.044 0.009 DBMET01637 0.041 0.012 DBMET01638 | DBMET01637 | |
| 0.108 | 0.079 | 0.108 | Caspase 3 inhibitor | 0.102 0.088 DBMET01637 | ||
| 0.119 | 0.091 | 0.13 | Vanilloid 1 agonist | 0.13 0.066 DBMET01637 0.128 0.07 DBMET01638 | DBMET01637 | |
| 0.061 | 0.034 | 0.071 | Carbonic anhydrase II inhibitor | 0.071 0.029 DBMET01637 | DBMET01637 | |
| 0.128 | 0.1 | 0.128 | Thiol protease inhibitor | |||
| 0.07 | 0.044 | 0.07 | Acetylcholine M5 receptor agonist | |||
| 0.089 | 0.062 | 0.089 | Potassium channel activator | |||
| 0.04 | 0.015 | 0.04 | Retinoid X alpha receptor antagonist | 0.035 0.022 DBMET01637 0.037 0.019 DBMET01638 | ||
| 0.036 | 0.011 | 0.036 | DNA topoisomerase IV inhibitor | |||
| 0.056 | 0.031 | 0.056 | 5 Hydroxytryptamine 1B agonist | |||
| 0.052 | 0.027 | 0.052 | Mineralocorticoid receptor antagonist | |||
| 0.042 | 0.018 | 0.042 | Vanilloid 3 antagonist | 0.038 0.028 DBMET01638 0.037 0.031 DBMET01639 | ||
| 0.041 | 0.018 | 0.041 | Fumarate hydratase inhibitor | 0.037 0.021 DBMET01637 0.039 0.02 DBMET01638 0.03 0.029 DBMET01639 | ||
| 0.146 | 0.124 | 0.146 | I kappa B kinase epsilon inhibitor | |||
| 0.043 | 0.022 | 0.046 | 5-Alpha-reductase inhibitor | 0.046 0.02 DBMET01637 | DBMET01637 | |
| 0.031 | 0.01 | 0.031 | Complement factor 1r inhibitor | 0.024 0.022 DBMET01638 0.024 0.023 DBMET01639 | ||
| 0.088 | 0.068 | 0.132 | Breast cancer-resistant protein inhibitor | 0.132 0.032 DBMET01637 0.107 0.049 DBMET01638 | DBMET01637 | |
| 0.041 | 0.021 | 0.056 | Inosine monophosphate dehydrogenase inhibitor | 0.056 0.012 DBMET01638 | DBMET01638 | |
| 0.042 | 0.022 | 0.043 | Retinoid X receptor agonist | 0.031 0.028 DBMET01637 0.043 0.021 DBMET01638 | DBMET01638 | |
| 0.029 | 0.01 | 0.029 | Glutamate (mGluR1) agonist | 0.025 0.015 DBMET01638 | ||
| 0.045 | 0.025 | 0.045 | DNA-dependent protein kinase inhibitor | 0.045 0.025 DBMET01637 | ||
| 0.04 | 0.021 | 0.058 | Nicotinic acid receptor agonist | 0.058 0.012 DBMET01637 0.032 0.031 DBMET01638 | DBMET01637 | |
| 0.043 | 0.024 | 0.043 | Kainate receptor agonist | 0.042 0.027 DBMET01637 0.042 0.028 DBMET01638 0.039 0.035 DBMET01639 | ||
| 0.046 | 0.027 | 0.046 | Leukocyte elastase inhibitor | |||
| 0.054 | 0.036 | 0.056 | Alpha-mannosidase inhibitor | 0.053 0.038 DBMET01637 0.056 0.033 DBMET01638 0.051 0.041 DBMET01639 | DBMET01638 | |
| 0.04 | 0.022 | 0.04 | Delayed rectifier potassium channel blocker | 0.036 0.028 DBMET01638 | ||
| 0.026 | 0.009 | 0.026 | Imidazoline I1 receptor antagonist | |||
| 0.07 | 0.053 | 0.07 | Phospholipase D inhibitor | |||
| 0.051 | 0.034 | 0.051 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.056 | 0.04 | 0.059 | Pregnane X receptor antagonist | 0.055 0.044 DBMET01637 0.059 0.034 DBMET01638 | DBMET01638 | |
| 0.065 | 0.049 | 0.065 | Potassium channel (ATP-sensitive) blocker | |||
| 0.056 | 0.04 | 0.059 | Leukotriene C antagonist | 0.059 0.03 DBMET01637 0.057 0.037 DBMET01638 0.057 0.038 DBMET01639 | DBMET01637 | |
| 0.055 | 0.039 | 0.055 | Immunoglobulin Fc receptor antagonist | 0.053 0.047 DBMET01638 | ||
| 0.027 | 0.012 | 0.052 | Estrone sulfatase inhibitor | 0.052 0.007 DBMET01637 0.019 0.018 DBMET01638 | DBMET01637 | |
| 0.062 | 0.048 | 0.087 | Dopamine D1 antagonist | 0.087 0.029 DBMET01637 0.058 0.052 DBMET01638 | DBMET01637 | |
| 0.095 | 0.082 | 0.095 | Factor V inhibitor | |||
| 0.094 | 0.082 | 0.127 | Protein kinase (CK2) alpha inhibitor | 0.127 0.057 DBMET01637 0.099 0.077 DBMET01638 | DBMET01637 | |
| 0.067 | 0.055 | 0.067 | Secretase beta inhibitor | |||
| 0.092 | 0.08 | 0.11 | mTOR complex 1 inhibitor | 0.11 0.043 DBMET01639 | DBMET01639 | |
| 0.034 | 0.023 | 0.034 | Free fatty acid receptor 1 antagonist | |||
| 0.015 | 0.004 | 0.015 | Progesterone receptor A antagonist | 0.015 0.004 DBMET01638 0.013 0.004 DBMET01639 | ||
| 0.197 | 0.187 | 0.197 | Beta lactamase inhibitor | |||
| 0.021 | 0.011 | 0.021 | 5-Alpha-reductase 1 inhibitor | 0.017 0.012 DBMET01637 | ||
| 0.097 | 0.087 | 0.115 | Adenylate cyclase inhibitor | 0.098 0.086 DBMET01637 0.115 0.071 DBMET01638 | DBMET01638 | |
| 0.05 | 0.04 | 0.051 | Protein 50S ribosomal subunit inhibitor | 0.051 0.039 DBMET01637 | DBMET01637 | |
| 0.038 | 0.029 | 0.038 | GABA uptake inhibitor | 0.037 0.031 DBMET01638 | ||
| 0.033 | 0.024 | 0.033 | Melatonin receptor 1A agonist | |||
| 0.036 | 0.027 | 0.036 | Integrin alpha2 antagonist | |||
| 0.026 | 0.018 | 0.026 | Integrin alpha2beta1 antagonist | |||
| 0.043 | 0.035 | 0.043 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.042 | 0.034 | 0.042 | Glutamate (mGluR group III) antagonist | |||
| 0.045 | 0.038 | 0.045 | Benzodiazepine antagonist | |||
| 0.025 | 0.018 | 0.026 | Vanilloid 2 agonist | 0.026 0.017 DBMET01637 0.026 0.017 DBMET01638 | DBMET01638 | |
| 0.151 | 0.144 | 0.176 | Platelet antagonist | 0.176 0.12 DBMET01637 | DBMET01637 | |
| 0.012 | 0.006 | 0.012 | Imidazoline I2 receptor antagonist | |||
| 0.05 | 0.044 | 0.083 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.083 0.015 DBMET01637 0.076 0.018 DBMET01638 | DBMET01637 | |
| 0.082 | 0.076 | 0.106 | Thioredoxin inhibitor | 0.106 0.041 DBMET01637 0.089 0.063 DBMET01638 | DBMET01637 | |
| 0.043 | 0.037 | 0.056 | Neuraminidase (Influenza A) inhibitor | 0.056 0.017 DBMET01637 | DBMET01637 | |
| 0.074 | 0.068 | 0.091 | MAP kinase kinase 7 inhibitor | 0.091 0.024 DBMET01637 0.088 0.028 DBMET01638 | DBMET01637 | |
| 0.042 | 0.036 | 0.043 | Mannosidase inhibitor | 0.041 0.038 DBMET01637 0.043 0.034 DBMET01638 | DBMET01638 | |
| 0.031 | 0.026 | 0.035 | Glutamate (mGluR3) agonist | 0.035 0.017 DBMET01637 0.033 0.02 DBMET01638 | DBMET01637 | |
| 0.064 | 0.059 | 0.064 | Amidase inhibitor | |||
| 0.083 | 0.079 | 0.101 | Protein kinase C zeta inhibitor | 0.101 0.049 DBMET01637 0.098 0.053 DBMET01638 | DBMET01637 | |
| 0.02 | 0.017 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.042 | 0.04 | 0.043 | Purinergic P2X4 antagonist | 0.043 0.038 DBMET01638 | DBMET01638 | |
| 0.099 | 0.096 | 0.14 | MAP kinase kinase inhibitor | 0.14 0.057 DBMET01637 | DBMET01637 | |
| 0.045 | 0.043 | 0.045 | HCV NS3/NS4A protease inhibitor | |||
| 0.023 | 0.021 | 0.023 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.024 | 0.023 | 0.024 | Complement factor 1s inhibitor | |||
| 0.041 | 0.04 | 0.056 | Microtubule stabilization | 0.056 0.02 DBMET01639 | DBMET01639 | |
| 0.045 | 0.044 | 0.045 | Prolyl endopeptidase inhibitor | |||
| 0.033 | 0.032 | 0.033 | Glutamate (mGluR3) antagonist | |||
| 0.068 | 0.067 | 0.068 | Phosphodiesterase VI inhibitor | |||
| 0.03 | 0.029 | 0.03 | Liver X receptor beta agonist | |||
| 0.077 | 0.078 | 0.098 | Potassium channel (Ca-activated) activator | 0.098 0.057 DBMET01637 0.095 0.06 DBMET01638 | DBMET01637 | |
| 0.036 | 0.038 | 0.038 | Leukotriene C4 antagonist | 0.038 0.03 DBMET01637 0.037 0.034 DBMET01638 | DBMET01637 | |
| 0.037 | 0.039 | 0.042 | CF transmembrane conductance regulator antagonist | 0.038 0.034 DBMET01637 0.042 0.022 DBMET01638 | DBMET01638 | |
| 0.015 | 0.018 | 0.016 | Telomerase stimulant | 0.016 0.014 DBMET01637 0.016 0.014 DBMET01638 | DBMET01638 | |
| 0.029 | 0.033 | 0.033 | RNA-directed RNA polymerase inhibitor | 0.033 0.026 DBMET01637 0.033 0.025 DBMET01638 | DBMET01638 | |
| 0.061 | 0.066 | 0.066 | Protein kinase C beta inhibitor | 0.066 0.055 DBMET01637 | DBMET01637 | |
| 0.028 | 0.033 | 0.047 | Arginase inhibitor | 0.047 0.017 DBMET01637 0.034 0.027 DBMET01638 | DBMET01637 | |
| 0.057 | 0.063 | 0.101 | Neuraminidase (influenza) inhibitor | 0.101 0.016 DBMET01637 | DBMET01637 | |
| 0.016 | 0.024 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.014 DBMET01637 | DBMET01637 | |
| 0.099 | 0.108 | 0.211 | Bone formation stimulant | 0.211 0.033 DBMET01637 | DBMET01637 | |
| 0.115 | 0.124 | 0.141 | Hemostatic | 0.141 0.08 DBMET01637 0.135 0.088 DBMET01638 | DBMET01637 | |
| 0.067 | 0.078 | 0.083 | Interferon agonist | 0.083 0.047 DBMET01638 | DBMET01638 | |
| 0.115 | 0.127 | 0.137 | Hexokinase inhibitor | 0.137 0.095 DBMET01637 0.123 0.114 DBMET01638 | DBMET01637 | |
| 0.045 | 0.058 | 0.053 | Leukotriene B4 antagonist | 0.052 0.041 DBMET01637 0.053 0.038 DBMET01638 | DBMET01638 | |
| 0.013 | 0.029 | 0.05 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.05 0.007 DBMET01637 0.032 0.011 DBMET01638 | DBMET01637 | |
| 0.023 | 0.04 | 0.03 | Estrogen-related receptor gamma antagonist | 0.03 0.015 DBMET01637 | DBMET01637 | |
| 0.115 | 0.132 | 0.167 | Mcl-1 antagonist | 0.167 0.076 DBMET01637 0.136 0.105 DBMET01638 | DBMET01637 | |
| 0.139 | 0.157 | 0.167 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.167 0.124 DBMET01638 | DBMET01638 | |
| 0.019 | 0.038 | 0.033 | Sodium/glucose cotransporter 2 inhibitor | 0.033 0.011 DBMET01639 | DBMET01639 | |
| 0.011 | 0.03 | 0.018 | Nicotinic acid receptor 1 antagonist | 0.018 0.012 DBMET01637 | DBMET01637 | |
| 0.051 | 0.07 | 0.057 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.057 0.051 DBMET01637 | DBMET01637 | |
| 0.028 | 0.048 | 0.037 | Urate transporter 1 inhibitor | 0.037 0.029 DBMET01638 | DBMET01638 | |
| 0.032 | 0.054 | 0.284 | Estrogen agonist | 0.284 0.005 DBMET01637 0.093 0.019 DBMET01638 | DBMET01637 | |
| 0.049 | 0.074 | 0.061 | CDC25B inhibitor | 0.061 0.049 DBMET01637 0.061 0.049 DBMET01638 | DBMET01638 | |
| 0.039 | 0.064 | 0.047 | Dopamine beta hydroxylase inhibitor | 0.047 0.038 DBMET01637 | DBMET01637 | |
| 0.028 | 0.054 | 0.165 | 5 Hydroxytryptamine 1A agonist | 0.165 0.01 DBMET01638 | DBMET01638 | |
| 0.019 | 0.047 | 0.028 | Sodium/glucose cotransporter inhibitor | 0.028 0.013 DBMET01639 | DBMET01639 | |
| 0.052 | 0.08 | 0.065 | Phosphodiesterase 4D inhibitor | 0.065 0.06 DBMET01637 | DBMET01637 | |
| 0.046 | 0.076 | 0.057 | Leukotriene antagonist | 0.057 0.055 DBMET01637 0.057 0.055 DBMET01638 | DBMET01638 | |
| 0.018 | 0.05 | 0.026 | Thyroid hormone agonist | 0.026 0.018 DBMET01637 0.024 0.022 DBMET01638 | DBMET01637 | |
| 0.05 | 0.086 | 0.059 | Interferon inducer | 0.059 0.057 DBMET01638 | DBMET01638 | |
| 0.054 | 0.09 | 0.288 | HIV-1 integrase inhibitor | 0.113 0.019 DBMET01637 0.288 0.004 DBMET01638 | DBMET01638 | |
| 0.049 | 0.086 | 0.06 | Sirtuin 1 inhibitor | 0.06 0.059 DBMET01638 | DBMET01638 | |
| 0.028 | 0.065 | 0.045 | Thromboxane A2 antagonist | 0.045 0.041 DBMET01638 | DBMET01638 | |
| 0.071 | 0.108 | 0.077 | CC chemokine 5 receptor agonist | 0.077 0.075 DBMET01638 | DBMET01638 | |
| 0.031 | 0.069 | 0.048 | Thromboxane antagonist | 0.048 0.044 DBMET01638 0.048 0.044 DBMET01639 | DBMET01639 | |
| 0.044 | 0.084 | 0.054 | Sphingosine kinase inhibitor | 0.054 0.052 DBMET01637 | DBMET01637 | |
| 0.054 | 0.1 | 0.073 | Metalloproteinase-2 inhibitor | 0.073 0.06 DBMET01638 | DBMET01638 | |
| 0.009 | 0.057 | 0.187 | Estrogen receptor beta agonist | 0.187 0.005 DBMET01637 0.088 0.013 DBMET01638 0.042 0.021 DBMET01639 | DBMET01637 | |
| 0.087 | 0.135 | 0.101 | Interleukin 8 antagonist | 0.101 0.093 DBMET01638 | DBMET01638 | |
| 0.04 | 0.091 | 0.087 | Lipase inhibitor | 0.087 0.036 DBMET01637 | DBMET01637 | |
| 0.066 | 0.118 | 0.133 | Uric acid excretion stimulant | 0.133 0.031 DBMET01637 0.106 0.047 DBMET01638 | DBMET01637 | |
| 0.048 | 0.103 | 0.065 | Beta 3 adrenoreceptor antagonist | 0.065 0.042 DBMET01637 | DBMET01637 | |
| 0.036 | 0.092 | 0.062 | Neutrophil collagenase inhibitor | 0.062 0.049 DBMET01638 | DBMET01638 | |
| 0.017 | 0.075 | 0.044 | Catechol O-methyltransferase inhibitor | 0.044 0.011 DBMET01637 0.039 0.015 DBMET01638 | DBMET01637 | |
| 0.036 | 0.096 | 0.085 | Dopamine agonist | 0.085 0.034 DBMET01637 | DBMET01637 | |
| 0.031 | 0.097 | 0.082 | Neuraminidase inhibitor | 0.082 0.024 DBMET01637 0.075 0.029 DBMET01639 | DBMET01637 | |
| 0.112 | 0.187 | 0.157 | Hypolipemic | 0.157 0.129 DBMET01637 0.148 0.139 DBMET01638 | DBMET01637 | |
| 0.054 | 0.13 | 0.105 | Antineoplastic alkaloid | 0.105 0.045 DBMET01637 0.096 0.05 DBMET01638 | DBMET01637 | |
| 0.059 | 0.145 | 0.102 | Alpha 2c adrenoreceptor antagonist | 0.102 0.064 DBMET01639 | DBMET01639 | |
| 0.092 | 0.188 | 0.245 | NOS3 expression enhancer | 0.245 0.028 DBMET01637 0.147 0.075 DBMET01638 | DBMET01637 | |
| 0.023 | 0.122 | 0.072 | Plasminogen activator inhibitor antagonist | 0.072 0.018 DBMET01638 | DBMET01638 | |
| 0.018 | 0.119 | 0.073 | Estrogen-related receptor beta antagonist | 0.073 0.004 DBMET01637 0.041 0.01 DBMET01638 | DBMET01637 | |
| 0.004 | 0.113 | 0.116 | Estrogen receptor alpha agonist | 0.116 0.007 DBMET01637 0.038 0.022 DBMET01638 | DBMET01637 | |
| 0.028 | 0.156 | 0.05 | Glucose-6-phosphate translocase inhibitor | 0.05 0.039 DBMET01637 | DBMET01637 | |
| 0.062 | 0.192 | 0.112 | T cell inhibitor | 0.112 0.017 DBMET01639 | DBMET01639 | |
| 0.1 | 0.233 | 0.163 | Lipocortins synthesis antagonist | 0.163 0.088 DBMET01638 | DBMET01638 | |
| 0.041 | 0.177 | 0.06 | Heme oxygenase stimulant | 0.06 0.045 DBMET01638 | DBMET01638 | |
| 0.012 | 0.149 | 0.049 | 5 Hydroxytryptamine 1 agonist | 0.049 0.038 DBMET01638 | DBMET01638 | |
| 0.041 | 0.186 | 0.18 | M18 aspartyl aminopeptidase inhibitor | 0.18 0.04 DBMET01637 0.159 0.048 DBMET01638 | DBMET01637 | |
| 0.005 | 0.174 | 0.038 | Squalene synthetase inhibitor | 0.038 0.019 DBMET01639 | DBMET01639 | |
| 0.018 | 0.189 | 0.091 | Maillard reaction inhibitor | 0.052 0.041 DBMET01637 0.091 0.02 DBMET01638 | DBMET01638 | |
| 0.071 | 0.244 | 0.153 | Farnesoid X receptor antagonist | 0.153 0.049 DBMET01637 0.128 0.086 DBMET01638 | DBMET01637 | |
| 0.011 | 0.186 | 0.037 | Estrogen-related receptor alpha antagonist | 0.037 0.019 DBMET01637 | DBMET01637 | |
| 0.024 | 0.212 | 0.048 | CXC chemokine 1 receptor antagonist | 0.048 0.041 DBMET01637 0.047 0.043 DBMET01638 | DBMET01637 | |
| 0.126 | 0.318 | 0.339 | Sodium/bile acid cotransporter inhibitor | 0.339 0.047 DBMET01637 0.299 0.08 DBMET01638 | DBMET01637 | |
| 0.013 | 0.216 | 0.054 | Alpha tubulin antagonist | 0.054 0.036 DBMET01637 | DBMET01637 | |
| 0.007 | 0.21 | 0.058 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.058 0.012 DBMET01637 0.031 0.028 DBMET01638 | DBMET01637 | |
| 0.024 | 0.245 | 0.06 | Cyclin B3 inhibitor | 0.06 0.056 DBMET01637 | DBMET01637 | |
| 0.013 | 0.236 | 0.106 | Acetyl-CoA carboxylase inhibitor | 0.106 0.004 DBMET01639 | DBMET01639 | |
| 0.086 | 0.326 | 0.13 | MAP kinase kinase 4 inhibitor | 0.13 0.114 DBMET01638 | DBMET01638 | |
| 0.039 | 0.343 | 0.102 | Toll-Like receptor 4 antagonist | 0.102 0.067 DBMET01637 | DBMET01637 | |
| 0.04 | 0.354 | 0.188 | Angiogenesis stimulant | 0.188 0.101 DBMET01637 | DBMET01637 | |
| 0.073 | 0.424 | 0.14 | Death-associated protein kinase 2 inhibitor | 0.14 0.131 DBMET01637 | DBMET01637 | |
| 0.028 | 0.389 | 0.196 | Thrombolytic | 0.196 0.054 DBMET01638 | DBMET01638 | |
| 0.095 | 0.469 | 0.176 | Peptidyltransferase inhibitor | 0.176 0.135 DBMET01637 | DBMET01637 | |
| 0.094 | 0.511 | 0.202 | Interleukin 2 agonist | 0.202 0.186 DBMET01637 | DBMET01637 | |
| 0.005 | 0.425 | 0.063 | Opioid kappa receptor agonist | 0.063 0.017 DBMET01639 | DBMET01639 | |
| 0.057 | 0.61 | 0.388 | Cyclophilin D inhibitor | 0.388 0.098 DBMET01638 0.237 0.228 DBMET01639 | DBMET01638 | |
| 0.012 | 0.819 | 0.44 | Toll-Like receptor 7 agonist | 0.44 0.046 DBMET01638 | DBMET01638 | |
| 0.01 | 0.83 | 0.432 | Toll-Like receptor agonist | 0.432 0.049 DBMET01638 | DBMET01638 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |